• earnings

Servier full year 2021/22 results confirm the transformation trajectory of the Group

PRNewswire February 2, 2023
  • Consolidated sales revenue of Ôé¼4.876 billion, up 9.8% (+6.6% at CERi), driven by strong growth in international sales
  • Sales revenue for brand-name medicines reached Ôé¼3.694 billion, up 12.5% (+8.9% at CERi), and Ôé¼1.182 billion for generics, up 2.0% (stable at CERi)
  • Important developments in oncology to address high unmet medical needs, particularly with Tibsovo┬« in the United States
  • Leadership maintained in cardiometabolism and venous diseases
  • A promising and balanced pipeline of R&D projects, offering hope in oncology, neuroscience and immuno-inflammation

PARIS, Feb. 2, 2023 /PRNewswire/ — Servier, an independent global pharmaceutical group, has announced its financial results for the 2021/22 financial year and highlighted the major steps of its ongoing transformation.

Excerpt of consolidated and audited results (IFRS standards[1], as of 30 September 2022)

(in Ôé¼ million)




at CER[i]

Group sales revenue



+9.8 %

+6.6 %

    Brand-name medicines revenue



+12.5 %

+8.9 %

    Generics revenue



+2.0 %

+0.0 %




+34.6 %

    EBITDA/Revenue ratio

17.6 %

14.4 %

+3.2 pts

Recurring operating result



+76 %

Net result




Olivier Laureau, President of Servier, said: “In a complex and unstable geopolitical and economic environment, progress has been made across all of Servier’s business segments,┬áreinforcing our transformation trajectory. I am proud of the work accomplished by our teams which underlines our daily commitment to patients. Servier is now a global healthcare player built around three balanced pillars: cardiometabolism and venous diseases, oncology, and generics. Our innovation capabilities have been strengthened and we now have a balanced and promising pipeline in line with our ambitions in oncology, neuroscience and immuno-inflammation. We are on track to meet our 2025 objectives and are moving forward with determination and confidence on our Servier 2030 strategic plan.”

Read the full press release in the attached PDF

Servier Logo (PRNewsfoto/Servier)

[1] In line with international standards, the Group now publishes its financial statements in accordance with IFRS norms (International Financial Reporting Standards). This transition facilitates the communication and comparability of our financial statements thanks to a standardized reference system.

[i] Variation at constant exchange rates (CER)


PDF – https://mma.prnewswire.com/media/1994433/Servier.pdf

SOURCE Servier

AAPR aggregates press releases and media statements from around the world to assist our news partners with identifying and creating timely and relevant news.

All of the press releases published on this website are third-party content and AAP was not involved in the creation of it. Read the full terms.